Atorvastatin	atorvastatin	S_chemicals	O
prevented	prevented	O	O
and	and	O	O
reversed	reversed	O	O
dexamethasone-induced	dexamethasone-induced	O	O
hypertension	hypertension	O	S_disease
in	in	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

To	to	O	O
assess	assess	O	O
the	the	O	O
antioxidant	antioxidant	B_chemicals	O
effects	effects	I_chemicals	O
of	of	O	O
atorvastatin	atorvastatin	S_chemicals	O
(	(	O	O
atorva	atorva	O	O
)	)	O	O
on	on	O	O
dexamethasone	dexamethasone	S_chemicals	O
(dex)-induced	(dex)-induced	O	O
hypertension	hypertension	O	S_disease
,	,	O	O
60	60	O	O
male	male	O	O
Sprague-Dawley	sprague-dawley	O	O
rats	rats	O	O
were	were	O	O
treated	treated	O	O
with	with	O	O
atorva	atorva	O	O
30	30	O	O
mg/kg/day	mg/kg/day	O	O
or	or	O	O
tap	tap	O	O
water	water	S_chemicals	O
for	for	O	O
15	15	O	O
days	days	O	O
.	.	O	O

Dex	dex	O	O
increased	increased	O	O
systolic	systolic	O	O
blood	blood	O	B_disease
pressure	pressure	O	I_disease
(	(	O	O
SBP	sbp	O	O
)	)	O	O
from	from	O	O
109	109	O	O
+	+	O	O
/-	/-	O	O
1.8	1.8	O	O
to	to	O	O
135	135	O	O
+	+	O	O
/-	/-	O	O
0.6	0.6	O	O
mmHg	mmhg	O	O
and	and	O	O
plasma	plasma	O	O
superoxide	superoxide	S_chemicals	O
(	(	O	O
5711	5711	O	O
+	+	O	O
/-	/-	O	O
284.9	284.9	O	O
saline	saline	O	O
,	,	O	O
7931	7931	O	O
+	+	O	O
/-	/-	O	O
392.8	392.8	O	O
U/ml	u/ml	O	O
dex	dex	O	O
,	,	O	O
P	p	O	O
<	<	O	O
0.001	0.001	O	O
)	)	O	O
.	.	O	O

In	in	O	O
this	this	O	O
prevention	prevention	O	O
study	study	O	O
,	,	O	O
SBP	sbp	O	O
in	in	O	O
the	the	O	O
atorva	atorva	O	O
+	+	O	O
dex	dex	O	O
group	group	O	O
was	was	O	O
increased	increased	O	O
from	from	O	O
115	115	O	O
+	+	O	O
/-	/-	O	O
0.4	0.4	O	O
to	to	O	O
124	124	O	O
+	+	O	O
/-	/-	O	O
1.5	1.5	O	O
mmHg	mmhg	O	O
,	,	O	O
but	but	O	O
this	this	O	O
was	was	O	O
significantly	significantly	O	O
lower	lower	O	O
than	than	O	O
in	in	O	O
the	the	O	O
dex-only	dex-only	O	O
group	group	O	O
(	(	O	O
P	p	B_chemicals	O
'	'	I_chemicals	O
<	<	O	O
0.05	0.05	O	O
)	)	O	O
.	.	O	O

Atorva	atorva	O	O
reversed	reversed	O	O
dex-induced	dex-induced	O	O
hypertension	hypertension	O	S_disease
(	(	O	O
129	129	O	O
+	+	O	O
/-	/-	O	O
0.6	0.6	O	O
mmHg	mmhg	O	O
,	,	O	O
vs.	vs.	O	O
135	135	O	O
+	+	O	O
/-	/-	O	O
0.6	0.6	O	O
mmHg	mmhg	O	O
P	p	B_chemicals	O
'	'	I_chemicals	O
<	<	O	O
0.05	0.05	O	O
)	)	O	O
and	and	O	O
decreased	decreased	O	O
plasma	plasma	O	O
superoxide	superoxide	S_chemicals	O
(	(	O	O
7931	7931	O	O
+	+	O	O
/-	/-	O	O
392.8	392.8	O	O
dex	dex	O	O
,	,	O	O
1187	1187	O	O
+	+	O	O
/-	/-	O	O
441.2	441.2	O	O
atorva	atorva	O	O
+	+	O	O
dex	dex	O	O
,	,	O	O
P	p	O	O
<	<	O	O
0.0001	0.0001	O	O
)	)	O	O
.	.	O	O

Plasma	plasma	O	O
nitrate/nitrite	nitrate/nitrite	O	O
(	(	O	O
NOx	nox	O	O
)	)	O	O
was	was	O	O
decreased	decreased	O	O
in	in	O	O
dex-treated	dex-treated	O	O
rats	rats	O	O
compared	compared	O	O
to	to	O	O
saline-treated	saline-treated	O	O
rats	rats	O	O
(	(	O	O
11.2	11.2	O	O
+	+	O	O
/-	/-	O	O
1.08	1.08	O	O
microm	microm	O	O
,	,	O	O
15.3	15.3	O	O
+	+	O	O
/-	/-	O	O
1.17	1.17	O	O
microm	microm	O	O
,	,	O	O
respectively	respectively	O	O
,	,	O	O
P	p	O	O
<	<	O	O
0.05	0.05	O	O
)	)	O	O
.	.	O	O

Atorva	atorva	O	O
affected	affected	O	O
neither	neither	O	O
plasma	plasma	O	O
NOx	nox	O	O
nor	nor	O	O
thymus	thymus	O	O
weight	weight	O	O
.	.	O	O

Thus	thus	O	O
,	,	O	O
atorvastatin	atorvastatin	S_chemicals	O
prevented	prevented	O	O
and	and	O	O
reversed	reversed	O	O
dexamethasone-induced	dexamethasone-induced	O	O
hypertension	hypertension	O	S_disease
in	in	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

